Recently, the Chinese-based audio manufacturer has released the Play, a “just add speakers” streaming amplifier that, ...

Both the A5+ and A15+ remain well equipped, with good-sounding digital inputs, a capable phono stage and handy two-way ...

Austin voters will decide on the city’s steepest property tax rate hike in at least 20 years this November. Facing a projected $33.4 million budget shortfall, the City Council approved a $6.3 billion ...

Shell Nigeria Exploration and Production Company Limited, a subsidiary of Shell plc, together with Sunlink Energies and Resources Limited, has taken a final investment decision on the HI gas project ...

Editor's Note: This Q&A has since ended, but you can still read the questions and answers from it at the bottom of this page. We're hoping to do a lot more of these in the not too distant future. If ...

Making a splash in Cannes, Mediawan Kids & Family world-premiered its early-school anime series “Ki & Hi in the Panda Kingdom” at MipJunior on Saturday, earning warm applause from industry attendees ...

Looking for an Amazon Big Deals Days discount on a new hi-fi setup? Then I’m pleased to report, while they're not on Amazon, a potent combination of deals will let you pick up the system I use in my ...

Middle Coast Investing, an investment advisor firm, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The third quarter was favorable for Middle Coast ...

Chaos In TPUSA: ‘Leaked’ Charlie Kirk Texts Spark Rift; Will Erika Kirk Move Against Candace Owens? Turning Point USA has reportedly descended into internal chaos after commentator Candace Owens began ...

The 2026 Kia Carnival Hi Limousine redefines premium MPV luxury with its taller roofline, VIP seating, and advanced features, launched in South Korea for families and fleets. In a world where SUVs ...

Most of Sky's most recent announcements have centred around its latest and greatest streaming devices, such as Glass and Stream. These products are clearly the future and that may have those with a ...

Braveheart Bio has waded into the fight for a heart disease market, paying (PDF) $65 million upfront for a rival to Bristol Myers Squibb’s Camzyos and Cytokinetics’ aficamten. Jiangsu Hengrui ...